Oncogenic Role of HMGB1 as An Alarming in Robust Prediction of Immunotherapy Response in Colorectal Cancer.

Huijiao LuMengyi ZhuLin QuHongwei ShaoRongxin ZhangYan Li

Published in: Cancers (2022)

HMGB1 is a potential novel biomarker for improving clinical prognosis and antitumor immunotherapy efficacy. CDK1, HMGB2, SSRP1, and H2AFV may serve as key nodes for HMGB1 in colorectal cancer.

Keyphrases

early stage
cell proliferation
human health
locally advanced